Recently, RBP‐Jκ has been shown to be overexpressed in various human cancers, such as osteosarcoma,7 glioblastoma8 and squamous cell skin carcinoma,9 indicating that it may be an oncogene or act as a tumour promoter. Here, RBPJ is linked to cancer.